Eli Lilly and Company

323.78-18.79-5.49%Vol 8.82M1Y Perf 36.57%
Feb 2nd, 2023 13:12 DELAYED
BID323.52 ASK323.79
Open334.00 Previous Close342.57
Pre-Market334.51 After-Market-
 -8.06 -2.35%  - -
Target Price
384.00 
Analyst Rating
Strong Buy 1.28
Potential %
19.13 
Finscreener Ranking
★+     43.66
Insiders Trans % 3/6/12 mo.
-100/-71/-71 
Value Ranking
     39.57
Insiders Value % 3/6/12 mo.
-100/-94/-94 
Growth Ranking
★★★★+     61.80
Insiders Shares Cnt. % 3/6/12 mo.
-100/-93/-93 
Income Ranking
     32.62
Price Range Ratio 52W %
60.24 
Earnings Rating
Sell
Market Cap307.65B 
Earnings Date
2nd Feb 2023
Alpha0.02 Standard Deviation0.07
Beta0.37 

Today's Price Range

317.00335.30

52W Range

231.87384.44

5 Year PE Ratio Range

-409.4043.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.56%
1 Month
-6.36%
3 Months
-3.49%
6 Months
6.99%
1 Year
36.57%
3 Years
145.32%
5 Years
321.99%
10 Years
595.52%

TickerPriceChg.Chg.%
LLY323.78-18.7900-5.49
AAPL150.214.77503.28
GOOG107.365.92505.84
MSFT261.588.83003.49
XOM111.73-3.0100-2.62
WFC47.360.33010.70
JNJ163.74-1.1800-0.72
FB196.640.99000.51
GE83.761.44001.75
JPM139.09-0.5050-0.36
 
ProfitabilityValueIndustryS&P 500US Markets
75.60
23.50
29.00
21.00
20.28
RevenueValueIndustryS&P 500US Markets
21.24B
22.35
6.88
4.56
DividendsValueIndustryS&P 500US Markets
1.29
4.52
12.71
11.34
Payout ratio47.00
Earnings HistoryEstimateReportedSurprise %
Q03 20221.971.980.51
Q02 20221.801.25-30.56
Q01 20222.322.6212.93
Q04 20212.512.49-0.80
Q03 20211.981.94-2.02
Q02 20211.891.87-1.06
Q01 20212.121.87-11.79
Q04 20202.352.7517.02
Earnings Per EndEstimateRevision %Trend
12/2022 QR1.91-7.28Negative
12/2022 FY7.76-2.76Negative
3/2023 QR1.915.52Positive
12/2023 FY8.18-12.70Negative
Next Report Date2nd Feb 2023
Estimated EPS Next Report1.83
Estimates Count7
EPS Growth Next 5 Years %19.80
Volume Overview
Volume8.82M
Shares Outstanding950.18K
Shares Float789.64M
Trades Count157.89K
Dollar Volume2.87B
Avg. Volume2.56M
Avg. Weekly Volume2.55M
Avg. Monthly Volume2.51M
Avg. Quarterly Volume2.63M

Eli Lilly and Company (NYSE: LLY) stock closed at 342.57 per share at the end of the most recent trading day (a -0.46% change compared to the prior day closing price) with a volume of 2.95M shares and market capitalization of 307.65B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 19500 people. Eli Lilly and Company CEO is David A. Ricks.

The one-year performance of Eli Lilly and Company stock is 36.57%, while year-to-date (YTD) performance is -6.36%. LLY stock has a five-year performance of 321.99%. Its 52-week range is between 231.87 and 384.44, which gives LLY stock a 52-week price range ratio of 60.24%

Eli Lilly and Company currently has a PE ratio of 54.60, a price-to-book (PB) ratio of 34.25, a price-to-sale (PS) ratio of 15.65, a price to cashflow ratio of 43.00, a PEG ratio of 2.32, a ROA of 13.67%, a ROC of 24.78% and a ROE of 72.51%. The company’s profit margin is 20.28%, its EBITDA margin is 29.00%, and its revenue ttm is $21.24 Billion , which makes it $22.35 revenue per share.

Of the last four earnings reports from Eli Lilly and Company, there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $1.83 for the next earnings report. Eli Lilly and Company’s next earnings report date is 02nd Feb 2023.

The consensus rating of Wall Street analysts for Eli Lilly and Company is Strong Buy (1.28), with a target price of $384, which is +19.13% compared to the current price. The earnings rating for Eli Lilly and Company stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eli Lilly and Company has a dividend yield of 1.29% with a dividend per share of $4.52 and a payout ratio of 47.00%.

Eli Lilly and Company has a Sell technical analysis rating based on Technical Indicators (ADX : 16.80, ATR14 : 10.77, CCI20 : -98.57, Chaikin Money Flow : -0.03, MACD : -4.95, Money Flow Index : 30.12, ROC : -5.27, RSI : 39.44, STOCH (14,3) : 49.13, STOCH RSI : 0.44, UO : 49.86, Williams %R : -50.87), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eli Lilly and Company in the last 12-months were: Alonzo Weems (Sold 1 968 shares of value $613 511 ), Anat Hakim (Option Excercise at a value of $0), Diogo Rau (Option Excercise at a value of $0), Donald A. Zakrowski (Sold 3 660 shares of value $1 019 214 ), Ilya Yuffa (Sold 2 000 shares of value $480 030 ), Jackson P. Tai (Buy at a value of $199 549), Jacob S. Van Naarden (Option Excercise at a value of $0), Marschall S. Runge (Buy at a value of $49 850), Patrik Jonsson (Sold 1 348 shares of value $353 659 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
13 (81.25 %)
13 (81.25 %)
11 (78.57 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (7.14 %)
Hold
2 (12.50 %)
2 (12.50 %)
2 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.28
Strong Buy
1.28
Strong Buy
1.32

Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

CEO: David A. Ricks

Telephone: +1 317 276-2000

Address: Lilly Corporate Center, Indianapolis 46285, IN, US

Number of employees: 19 500

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

49%51%

Bearish Bullish

64%36%

Bearish Bullish

59%41%

TipRanks News for LLY

Tue, 31 Jan 2023 16:35 GMT Eli Lilly & Co (LLY) Gets a Buy from Barclays

- TipRanks. All rights reserved.

Mon, 23 Jan 2023 14:35 GMT Eli Lilly & Co (LLY) Gets a Buy from BMO Capital

- TipRanks. All rights reserved.

Thu, 19 Jan 2023 13:10 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Roche Holding AG (OtherRHHVF) and Avidity Biosciences (RNA)

- TipRanks. All rights reserved.

Mon, 09 Jan 2023 15:00 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Alnylam Pharma (ALNY) and G1 Therapeutics (GTHX)

- TipRanks. All rights reserved.

Fri, 16 Dec 2022 12:30 GMT Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), HCA Healthcare (HCA)

- TipRanks. All rights reserved.

Wed, 14 Dec 2022 14:40 GMT Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ligand Pharma (LGND)

- TipRanks. All rights reserved.

Wed, 14 Dec 2022 12:10 GMT Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Eli Lilly & Co (LLY) and Irhythm Technologies (IRTC)

- TipRanks. All rights reserved.

Tue, 06 Dec 2022 16:30 GMT Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), AbbVie (ABBV) and Mirati Therapeutics (MRTX)

- TipRanks. All rights reserved.

Fri, 02 Dec 2022 14:50 GMT Analysts Top Healthcare Picks: Eli Lilly & Co (LLY), Rigel (RIGL)

- TipRanks. All rights reserved.

Mon, 14 Nov 2022 14:51 GMT Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Crispr Therapeutics AG (CRSP)

- TipRanks. All rights reserved.

Mon, 07 Nov 2022 14:50 GMT Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY), ImmunoGen (IMGN) and Bausch Health Companies (BHC)

- TipRanks. All rights reserved.

Wed, 02 Nov 2022 12:43 GMT Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Idexx Laboratories (IDXX) and Waters (WAT)

- TipRanks. All rights reserved.

Mon, 31 Oct 2022 14:12 GMT Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), AbbVie (ABBV)

- TipRanks. All rights reserved.

Sat, 15 Oct 2022 12:15 GMT Eli Lilly & Co (LLY) Gets a Buy from J.P. Morgan

- TipRanks. All rights reserved.

Mon, 03 Oct 2022 14:10 GMT Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (LLY) and Alnylam Pharma (ALNY)

- TipRanks. All rights reserved.

Mon, 26 Sep 2022 13:50 GMT Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), AbCellera Biologics (ABCL)

- TipRanks. All rights reserved.

Wed, 27 Jul 2022 03:26 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), HCA Healthcare (HCA) and Universal Health (UHS)

- TipRanks. All rights reserved.

News

Stocktwits